AdisInsight：2024探索生物类似药的潜力：历史成就与未来前景研究报告（英文版）（37页）.pdf

1、Unveiling the Potential of Biosimilars:Past Achievements and Future P2ContentsIntroduction3Biosimilars versus generics3Advantages of biosimilars3Global distribution of biosimilars approvals(5 years)4The first biosimilar9Change in regulatory guidelines for the approval process10Interchangeable biosim

2、ilars10Sales analysis of reference biologic post biosimilar launch(2019-2023)11Comparative account of Year-Over-Year sales of reference products16Global distribution of launched biosimilars18Key players in the market for launched biosimilars19The next wave of biosimilars20Global distribution of upco

3、ming biosimilars27Key players in the upcoming market29Conclusion30References32Unveiling the Potential of Biosimilars:Past Achievements and Future Prospects IntroductionBiosimilars are safe and effective treatment options for many illnesses,such as chronic skin and bowel diseases(like psoriasis,irrit

4、able bowel syndrome,Crohns disease,and colitis),arthritis,kidney conditions,and cancer.These medicines are very close in structure and function to biologic medicines and increase access to lifesaving medications at potentially lower costs.They are highly similar to a biologic medication already appr

5、oved by a regulatory body the original biologic(also called the reference product).Both a biosimilar and its original biologic:Are made from the same types of sources(e.g.living sources)Provide the same benefits when treating diseases or medical conditions Are provided at the same strength and dosag

6、e Are not expected to cause new or worsening side effectsBiosimilars versus genericsBiosimilars and Generics are alternate versions of medications that are already approved by a regulatory body,but these two types of medicines show some significant differences:Advantages of biosimilars Biosimilars p